# A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT07288554** · PHASE1 · RECRUITING · sponsor: **Bambusa Therapeutics** · enrollment: 68 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** BBT002
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07288554
- **Lead sponsor:** Bambusa Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-05-30
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07288554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07288554, "A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07288554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*